|
Q4 FY2025
As of Sep 30, 2025
|
Q4 FY2024
As of Sep 30, 2024
|
Q4 FY2023
As of Sep 30, 2023
|
Q4 FY2022
As of Sep 30, 2022
|
Q4 FY2021
As of Sep 30, 2021
|
Q4 FY2020
As of Sep 30, 2020
|
Q4 FY2019
As of Sep 30, 2019
|
Q4 FY2018
As of Sep 30, 2018
|
Q4 FY2017
As of Sep 30, 2017
|
Q4 FY2016
As of Sep 30, 2016
|
Q4 FY2015
As of Sep 30, 2015
|
Q4 FY2014
As of Sep 30, 2014
|
Q4 FY2013
As of Sep 30, 2013
|
Q4 FY2012
As of Sep 30, 2012
|
Q4 FY2011
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Short-term interest-bearing investments | |||||||||||||||
| Accounts receivable, net | |||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Lease assets | |||||||||||||||
| Goodwill | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Other noncurrent assets | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||
| Accrued personnel costs | |||||||||||||||
| Lease liabilities | |||||||||||||||
| Deferred revenue | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred income taxes and taxes payable | |||||||||||||||
| Lease liabilities | |||||||||||||||
| Long-term debt, net of unamortized debt issuance costs | |||||||||||||||
| Other noncurrent liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Amdocs Limited Shareholders' equity: | |||||||||||||||
| Preferred Shares - Authorized 25,000 shares; 0.01 par value; 0 shares issued and outstanding | |||||||||||||||
| Ordinary Shares - Authorized 700,000 shares; 0.01 par value; 290,351 and 288,485 issued and 108,448 and 112,891 outstanding, in 2025 and 2024, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Treasury stock, at cost 181,903 and 175,594 ordinary shares, in 2025 and 2024, respectively | |||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||
| Retained earnings | |||||||||||||||
| Total Amdocs Limited Shareholders' equity | |||||||||||||||
| Noncontrolling interests | |||||||||||||||
| Total equity | |||||||||||||||
| Total liabilities and equity | |||||||||||||||
Loading...